Angiosarcoma after breast-conserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART).

@article{Smith2014AngiosarcomaAB,
  title={Angiosarcoma after breast-conserving therapy: long-term disease control and late effects with hyperfractionated accelerated re-irradiation (HART).},
  author={Tamara L. Smith and Christopher G. Morris and Nancy Price Mendenhall},
  journal={Acta oncologica},
  year={2014},
  volume={53 2},
  pages={
          235-41
        }
}
BACKGROUND Secondary angiosarcoma is a malignant cancer that develops in approximately 1% of patients treated with breast-conserving therapy (BCT) for primary breast cancer. Most treatments for secondary angiosarcoma have been unsuccessful and no consensus has been reached on what is the best therapeutic strategy. We report long-term outcomes of patients with secondary angiosarcoma treated with hyperfractionated and accelerated re-irradiation (HART). MATERIAL AND METHODS We retrospectively… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

[Secondary Angiosarcoma of the Breast after Breast-conserving Therapy].

  • P. Wiebringhaus, Andreas Gröger, Henrik Menke
  • Medicine
  • Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...
  • 2014